Yang YS, Min KW, Park SO, Kim KS, et al. Efficacy and Safety of Monotherapy with Enavogliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results of a 12-week, multi-center, randomized, double-blind, placebo-controlled, phase 2 trial. Diabetes Obes Metab 2023 Apr 4. doi: 10.1111/dom.15080.
PMID: 37016484